设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
SpringerLink电子期刊(3)
Elsevier电子期刊(17)
在“
Elsevier电子期刊
”中,
命中:
17
条,耗时:0.0299673 秒
在所有数据库中总计命中:
20
条
1.
Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial
作者:
Prof
Ludwig
Kappos
;
MD
a
;
ludwig
.
kappos
@usb.ch" class="auth_mail" title="E-mail the corresponding author
;
Prof
Douglas L Arnold
;
MD
b
;
Prof
Amit Bar-Or
;
MD
b
;
Prof
John Camm
;
MD
c
;
Prof
Tobias Derfuss
;
MD
a
;
Prof
Bernd C Kieseier
;
MD
d
;
Prof
Till Sprenger
;
MD
a
;
Kristin Greenough
;
MSc
e
;
Pingping Ni
;
PhD
e
;
Tomohiko Harada
;
MD
e
刊名:Lancet Neurology
出版年:2016
2.
Safety and tolerability
prof
ile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies
作者:
Gavin Giovannoni
a
;
g.giovannoni@qmul.ac.uk" class="auth_mail" title="E-mail the corresponding author
;
Ludwig
Kappos
b
;
ludwig
.
kappos
@usb.ch" class="auth_mail" title="E-mail the corresponding author
;
Ralf Gold
c
;
Ralf.Gold@ruhr-uni-bochum.de" class="auth_mail" title="E-mail the corresponding author
;
Bhupendra O Khatri
d
;
bokhatri@aol.com" class="auth_mail" title="E-mail the corresponding author
;
Krzysztof Selmaj
e
;
kselmaj@afazja.am.lodz.pl" class="auth_mail" title="E-mail the corresponding author
;
Kimberly Umans
f
;
kim.umans@biogen.com" class="auth_mail" title="E-mail the corresponding author
;
Steven J Greenberg
g
;
steven.greenberg@abbvie.com" class="auth_mail" title="E-mail the corresponding author
;
Marianne Sweetser
f
;
1
;
msweetser@alnylam.com" class="auth_mail" title="E-mail the corresponding author
;
Jacob Elkins
f
;
jake.elkins@biogen.com" class="auth_mail" title="E-mail the corresponding author
;
Peter McCroskery
f
;
peter.mccroskery@biogen.com" class="auth_mail" title="E-mail the corresponding author
关键词:
AE
;
adverse event
;
ALT
;
alanine aminotransferase
;
AST
;
aspartate aminotransferase
;
DRESS
;
drug reaction with eosinophilia and systematic symptoms
;
DSMB
;
data safety monitoring board
;
GGT
;
gamma-glutamyl transferase
;
GI
;
gastrointestinal
;
IL-2
;
interleukin 2
;
IM
;
intramuscular
;
MedDRA
;
Medical Dictionary for Regulatory Activities
;
MS
;
multiple sclerosis
;
RRMS
;
relapsing-remitting multiple sclerosis
;
SAE
;
serious adverse event
;
SMQ
;
Standardised MedDRA Query
;
SOC
;
System Organ Class
;
ULN
;
upper li
刊名:Multiple Sclerosis and Related Disorders
出版年:2016
3.
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
作者:
Prof
Fred Lublin
;
MD
a
;
*
;
fred.lublin@mssm.edu" class="auth_mail" title="E-mail the corresponding author
;
Prof
David H Miller
;
FMedSci
b
;
*
;
Prof
Mark S Freedman
;
MD
c
;
Prof
Bruce A C Cree
;
MD
d
;
Prof
Jerry S Wolinsky
;
MD
e
;
Prof
Howard Weiner
;
MD
f
;
Prof
Catherine Lubetzki
;
MD
g
;
Prof
Hans-Peter Hartung
;
MD
h
;
Prof
Xavier Montalban
;
MD
i
;
Prof
Bernard M J Uitdehaag
;
MD
j
;
Martin Merschhemke
;
MD
k
;
Bingbing Li
;
PhD
l
;
Norman Putzki
;
MD
k
;
Fonda C Liu
;
PharmD
l
;
Dieter A Hä
;
ring
;
PhD
k
;
Prof
Ludwig
Kappos
;
MD
m
;
on behalf of the INFORMS study investigators
&dagger
;
刊名:The Lancet
出版年:2016
4.
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
作者:
Prof
Massimo Filippi
;
MD
a
;
filippi.massimo@hsr.it" class="auth_mail" title="E-mail the corresponding author
;
Maria A Rocca
;
MD
a
;
Prof
Olga Ciccarelli
;
PhD
b
;
c
;
Nicola De Stefano
;
MD
d
;
Nikos Evangelou
;
PhD
e
;
Prof
Ludwig
Kappos
;
MD
f
;
Alex Rovira
;
MD
g
;
Jaume Sastre-Garriga
;
MD
h
;
Mar Tintorè
;
MD
h
;
Prof
Jette L Frederiksen
;
MD
i
;
Claudio Gasperini
;
MD
j
;
Jacqueline Palace
;
MD
k
;
Daniel S Reich
;
MD
l
;
Prof
Brenda Banwell
;
MD
m
;
Prof
Xavier Montalban
;
MD
h
;
Prof
Frederik Barkhof
;
MD
n
;
on behalf of the MAGNIMS Study Group
&dagger
;
刊名:Lancet Neurology
出版年:2016
5.
Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
作者:
Giancarlo Comi
a
;
g.comi@hsr.it" class="auth_mail" title="E-mail the corresponding author
;
Mark S Freedman
b
;
mfreedman@toh.on.ca" class="auth_mail" title="E-mail the corresponding author
;
Ludwig
Kappos
c
;
Ludwig
.
Kappos
@usb.ch" class="auth_mail" title="E-mail the corresponding author
;
Tomas P Olsson
d
;
Tomas.Olsson@ki.se" class="auth_mail" title="E-mail the corresponding author
;
Aaron E Miller
e
;
aaron.miller@mssm.edu" class="auth_mail" title="E-mail the corresponding author
;
Jerry S Wolinsky
f
;
Jerry.S.Wolinsky@uth.tmc.edu" class="auth_mail" title="E-mail the corresponding author
;
Paul W O'Connor
g
;
opaul362@gmail.com" class="auth_mail" title="E-mail the corresponding author
;
Myriam Benamor
h
;
Myriam.Benamor@sanofi.com" class="auth_mail" title="E-mail the corresponding author
;
Deborah Dukovic
i
;
Deborah.Dukovic@sanofi.com" class="auth_mail" title="E-mail the corresponding author
;
Philippe Truffinet
h
;
Philippe.Truffinet@sanofi.com" class="auth_mail" title="E-mail the corresponding author
;
Thomas P Leist
j
;
Thomas.Leist@jefferson.edu" class="auth_mail" title="E-mail the corresponding author
关键词:
Multiple sclerosis
;
Relapsing-remitting multiple sclerosis
;
Teriflunomide
;
Safety analysis
;
Clinical trials
刊名:Multiple Sclerosis and Related Disorders
出版年:2016
6.
Efficacité et sécurité de l’ocrelizumab chez les patients atteints de sclérose en plaques récurrente : résultats d’OPERA I et II, études de phase III, en double-insu, double-placebo, versus interféron bêta-1a
作者:
Sandra Vukusic
1
;
sandra.vukusic@chu-lyon.fr" class="auth_mail" title="E-mail the corresponding author
;
Stephen L. Hauser
2
;
Douglas Arnold
3
;
Anthony Traboulsee
4
;
Gaelle Klingelschmitt
5
;
Hideki Garren
6
;
Ludwig
Kappos
7
关键词:
SEP ré
;
currente
;
É
;
tudes OPERA I et II
;
Ocrelizumab
刊名:Revue Neurologique
出版年:2016
7.
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
作者:
Dr Peter A Calabresi
;
MD
a
;
pcalabr1@jhmi.edu" class="auth_mail
;
Prof
Ernst-Wilhelm Radue
;
MD
b
;
Douglas Goodin
;
MD
d
;
Douglas Jeffery
;
MD
e
;
Kottil W Rammohan
;
MD
f
;
Anthony T Reder
;
MD
g
;
Timothy Vollmer
;
MD
h
;
Mark A Agius
;
MD
i
;
j
;
Prof
Ludwig
Kappos
;
MD
c
;
Tracy Stites
;
PhD
k
;
Bingbing Li
;
PhD
k
;
Linda Cappiello
;
MD
k
;
Philipp von Rosenstiel
;
MD
l
;
Fred D Lublin
;
MD
m
刊名:Lancet Neurology
出版年:June 2014
8.
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
作者:
Prof
Ludwig
Kappos
;
MD
a
;
ludwig
.
kappos
@usb.ch" class="auth_mail
;
Prof
Hans-Peter Hartung
;
MD
c
;
Prof
Mark S Freedman
;
MD
d
;
Prof
Alexey Boyko
;
MD
e
;
Prof
Ernst Wilhelm Radü
;
MD
b
;
Daniel D Mikol
;
MD
f
;
Marc Lamarine
;
PhD
g
;
Yann Hyvert
;
PhD
h
;
Ulrich Freudensprung
;
MS
i
;
Thomas Plitz
;
PhD
j
;
Johan van Beek
;
PhD
k
;
for the ATAMS Study Group &dagger
刊名:Lancet Neurology
出版年:April, 2014
9.
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
作者:
Christian Confavreux
;
Paul O'Connor
;
Giancarlo Comi
;
Mark S Freedman
;
Aaron E Miller
;
Tomas P Olsson
;
Jerry S Wolinsky
;
Teresa Bagulho
;
Jean-Luc Delhay
;
Deborah Dukovic
;
Philippe Truffinet
;
Ludwig
Kappos
;
for the TOWER Trial Group
刊名:Lancet Neurology
出版年:March, 2014
10.
Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study
作者:
Virginia Devonshire
;
MD
a
;
Eva Havrdova
;
MD
b
;
Prof
Ernst Wilhelm Radue
;
MD
c
;
Paul O'Connor
;
MD
d
;
Lixin Zhang-Auberson
;
MD
e
;
Catherine Agoropoulou
;
PhD
e
;
Dieter Adrian Hä
;
ring
;
PhD
e
;
Gordon Francis
;
MD
f
;
Prof
Ludwig
Kappos
;
MD
c
;
l
kappos
@uhbs.ch
;
for the FREEDOMS study group
&Dagger
;
刊名:Lancet Neurology
出版年:2012
1
2
按检索点细分(17)
作者(7)
按出版年细分(17)
2027年及以后(3)
2016年(6)
2012年(2)
2011年(1)
2009年(2)
2008年(2)
2001年(1)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.